Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Holmes

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Veterinary Record|July 5, 1997
Neurological condition in polled Dorset lambsG P David, J P Holmes, W F Adams
The Veterinary Record|May 7, 2021
Sympatric cases of squirrelpox in red and grey squirrelsCraig Shuttleworth, David Everest, C Wood, et al.
Dento Maxillo Facial Radiology|September 26, 2001
Detection of simulated internal tooth resorption using conventional radiography and subtraction imagingJ P Holmes, K Gulabivala, P F van der Stelt
The Veterinary Record|November 14, 2020
Maintaining wildlife monitoring during lockdownD J Everest, C M Shuttleworth, J P Holmes, et al.
Journal of Autism and Developmental Disorders|March 31, 1999
Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autismN A Dartnall, J P Holmes, S N Morgan, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot studyM N Potenza, J P Holmes, S J Kanes, et al.
The Veterinary Record|June 13, 2020
Suspected collision trauma deaths in pied wagtailsJ P Duff, M Richey, J P Holmes, et al.
The Veterinary Record|July 23, 2021
Botulism and Bisgaard taxon implicated in Arctic tern deaths in the UKJ P Duff, Lisa Thurston, J P Holmes, et al.
Archives of General Psychiatry|July 22, 1998
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disordersC J McDougle, J P Holmes, D C Carlson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2014
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patientsE A Mittendorf, G T Clifton, J P Holmes, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Veterinary Record|July 5, 1997
Neurological condition in polled Dorset lambsG P David, J P Holmes, W F Adams
The Veterinary Record|May 7, 2021
Sympatric cases of squirrelpox in red and grey squirrelsCraig Shuttleworth, David Everest, C Wood, et al.
Dento Maxillo Facial Radiology|September 26, 2001
Detection of simulated internal tooth resorption using conventional radiography and subtraction imagingJ P Holmes, K Gulabivala, P F van der Stelt
The Veterinary Record|November 14, 2020
Maintaining wildlife monitoring during lockdownD J Everest, C M Shuttleworth, J P Holmes, et al.
Journal of Autism and Developmental Disorders|March 31, 1999
Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autismN A Dartnall, J P Holmes, S N Morgan, et al.
Journal of Clinical Psychopharmacology|February 6, 1999
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot studyM N Potenza, J P Holmes, S J Kanes, et al.
The Veterinary Record|June 13, 2020
Suspected collision trauma deaths in pied wagtailsJ P Duff, M Richey, J P Holmes, et al.
The Veterinary Record|July 23, 2021
Botulism and Bisgaard taxon implicated in Arctic tern deaths in the UKJ P Duff, Lisa Thurston, J P Holmes, et al.
Archives of General Psychiatry|July 22, 1998
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disordersC J McDougle, J P Holmes, D C Carlson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2014
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patientsE A Mittendorf, G T Clifton, J P Holmes, et al.
Pageof 3